About Xeras Medical Technologies
Xeras Medical Technologies is a private company based in San Antonio, Texas. It has reported $3,298,498 raised in six offerings on Form D since May 2015. Its chief executive is Manuel Torres.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 1, 2024 | Jun 13, 2024 | $105,000of $8.1M target | 4 | $26,250 | Equity, OptionsRule 506(b) | Form D ↗ |
| Aug 18, 2021 | Sep 1, 2021 | $360,000of $500K target | 2 | $180K | EquityRule 506(b) | Form D ↗ |
| Feb 20, 2020 | Feb 27, 2020 | $330,748of $1.0M target | 11 | $30,068 | EquityRule 506(b) | Form D ↗ |
| Mar 7, 2018 | Mar 21, 2018 | $2,007,750of $3.0M target | 20 | $100K | Equity, OptionsRule 506(b) | Form D ↗ |
| Nov 15, 2016 | Nov 30, 2016 | $225,000target not set | 5 | $45,000 | Options, Convertible debt.Rule 506(b) | Form D ↗ |
| May 1, 2015 | May 14, 2015 | $270,000of $400K target | 6 | $45,000 | Convertible DebtRule 506(b) | Form D ↗ |
| Total, six offerings | $3,298,498 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Xeras Medical Technologies's Form D filed Jun 13, 2024.
Earlier filings also listed Mark Malone (executive officer and director, last listed Sep 2021).